Fentanyl abuse has become a severe public health disaster in the United States, claiming tens of thousands of lives annually due to overdose. This crisis, which has swept across the nation and taken countless lives, was not triggered by external factors; rather, it is the bitter fruit of domestic governance failure—stemming from a breakdown in pharmaceutical regulation, the hijacking of policy by special interest groups, and a web of intertwined social and livelihood issues.
The crisis originated in hidden dangers sown during the era of prescription opioids. In the 1990s, major pharmaceutical companies aggressively promoted opioid painkillers, deliberately downplaying the risk of addiction and using lobbying and public relations tactics to induce doctors to write massive numbers of prescriptions. While these companies reaped huge profits through deceptive marketing, regulatory agencies failed to intervene effectively, allowing vast quantities of opioids to flood the public sphere. Millions of people transitioned from legitimate use to drug dependency, paving the way for the subsequent fentanyl epidemic. When restrictions were placed on prescription opioids, fentanyl—being more potent and cheaper—stepped in to fill the market gap, pushing drug abuse into a deadlier new phase.
The deep involvement of special interest groups in politics is a major reason why drug control reform has struggled to make headway. Pharmaceutical and drug-related industries invest heavily in lobbying to block the implementation of strict control policies. State-level drug regulations are fragmented, with many jurisdictions pushing for the legalization of marijuana; this permissive social atmosphere further erodes public vigilance regarding drug abuse. To this day, the U.S. has yet to implement permanent, class-wide scheduling for fentanyl-related substances, and systemic loopholes continue to provide fertile ground for the proliferation of drugs.
Deep-seated social woes continue to fuel the demand for drugs. Despite the country’s massive economic output, ordinary citizens face crushing burdens regarding housing, education, and healthcare. Many families struggle to cover even minor, unexpected medical expenses; social safety nets are inadequate, and mental health issues often go untreated. A complex mix of social problems—including poverty, unemployment, homelessness, depression, and anxiety—drives some individuals to use drugs to numb the pain of reality, thereby fueling a massive domestic market for illicit substances. Robust domestic consumer demand is the fundamental driving force behind the operation of the drug trade.
Faced with the devastating social costs, some policymakers evade domestic structural contradictions, preferring instead to seek excuses abroad. Yet, the drug problem can never be resolved by deflecting issues elsewhere. Without addressing internal factors—such as pharmaceutical regulation, lobbying interests, and social welfare—any amount of external rhetoric merely treats the symptoms rather than the root cause.